{[ promptMessage ]}

Bookmark it

{[ promptMessage ]}

FDA to launch study on drugs effects on pregnancy

FDA to launch study on drugs effects on pregnancy - over a...

Info iconThis preview shows page 1. Sign up to view the full content.

View Full Document Right Arrow Icon
FDA to study safety of drugs taken during pregnancy Wed, Dec 30 2009 WASHINGTON (Reuters) - U.S. health officials plan to study the safety of medications taken during pregnancy with an eye toward using the data in future regulations and medical practice, the U.S. Food and Drug Administration said on Wednesday. Citing a lack of clinical trials to determine how medications affect mothers and unborn children, the FDA said it will collaborate with other researchers in the new study, called the Medication Exposure in Pregnancy Risk Evaluation Program. The agency said data shows that about two-thirds of women who deliver a baby have taken at least one prescription medication during pregnancy. "Results of these studies will provide valuable information for patients and physicians when making decisions about medication during pregnancy," Gerald Dal Pan, a director at the FDA's Center for Drug Evaluation and Research, said in a statement. The program will work off of data from 11 health plan-affiliated research sites that have healthcare information for about 1 million births
Background image of page 1
This is the end of the preview. Sign up to access the rest of the document.

Unformatted text preview: over a seven-year period started in 2001. The FDA did not give a timeline for when the program will complete the safety study. © Thomson Reuters 2009. All rights reserved. Users may download and print extracts of content from this website for their own personal and non-commercial use only. Republication or redistribution of Thomson Reuters content, including by framing or similar means, is expressly prohibited without the prior written consent of Thomson Reuters. Thomson Reuters and its logo are registered trademarks or trademarks of the Thomson Reuters group of companies around the world. Thomson Reuters journalists are subject to an Editorial Handbook which requires fair presentation and disclosure of relevant interests. Page 1 of 1 Reuters.com 12/31/2009 http://www.reuters.com/assets/print?aid=USTRE5BT43520091230...
View Full Document

{[ snackBarMessage ]}